Claris Lifesciences Recalls Levofloxacin Injection Due to Sterility Concerns
Claris Lifesciences Inc. is recalling Levofloxacin Injection due to a potential leak that may compromise sterility. The recall covers 24,456 units distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. Per the rubric, FDA Class II recalls with potential for significant injury (such as infection from a sterility breach in an IV product) are rated as Severe (4), as they are not Class I but involve risks beyond minor labeling errors.
Plain-English summary
Claris Lifesciences Inc. is recalling specific lots of Levofloxacin Injection in 5% Dextrose, 750 mg in 150 mL. The recall is due to a lack of assurance of sterility, as there is a potential for a leak from the primary container which may result in a breach of sterility and contamination of the product.
The affected product is Lot A060040, with an expiration date of December 2017. A total of 24,456 units (1,019 cartons containing 24 bags each) were distributed nationwide. The product is a prescription-only intravenous antibiotic manufactured for Claris Lifesciences Inc. in North Brunswick, NJ, by Claris Injectable Ltd. in Gujarat, India.
Patients and healthcare providers should stop using the affected product and contact their healthcare provider for further instructions. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- LEVOFLOXACIN (LEVOFLOXACIN)
- Brand
- LEVOFLOXACIN
- Manufacturer
- Claris Lifesciences Inc
- Category
- Drug — Antibiotic
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: A060040
- Exp. Dec 2017
UPCs (3)
- 0336000047241
- 0336000045018
- 0336000046244
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 4 recalled by Claris Lifesciences Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same brand · LEVOFLOXACIN
- HighLevofloxacin 500 mg Tablets Recalled Due to Manufacturing Temperature Abuse
FDA (Drugs) · 2022-06-15
- SevereCardinal Health Recalls Levofloxacin Injection Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateBaxter Recalls Levofloxacin Injection Bags Due to High Potency
FDA (Drugs) · 2018-10-03
- LowBaxter Recalls Levofloxacin Injection Due to High Potency Levels
FDA (Drugs) · 2018-08-15
- ModerateBaxter Recalls Levofloxacin Injection Due to High Concentration Levels
FDA (Drugs) · 2018-08-15
Same manufacturer · Claris Lifesciences Inc
See all →- ModerateClaris Recalls Ciprofloxacin Injection Due to Superpotency
FDA (Drugs) · 2017-12-27
- SevereClaris Ciprofloxacin Injection Recalled for Potential Sterility Breach
FDA (Drugs) · 2017-04-05
- SevereClaris Fluconazole Injection Recalled for Potential Sterility Breach
FDA (Drugs) · 2017-04-05
- SevereClaris Recalls Metronidazole Injection Due to Sterility Concerns
FDA (Drugs) · 2017-04-05
Same hazard · sterility breach
See all →- ModerateMedline Kits with Zimmer Biomet Mixing Bowls and Spatulas Recalled
FDA (Devices) · 2026-07-22
- ModerateMedline Kits with Zimmer Biomet Mixing Bowls Recalled for Seal Defects
FDA (Devices) · 2026-07-22
- HighIntracept Access Instruments sterile barrier breach risk
FDA (Devices) · 2026-07-15
- ModerateSterile Tourniquet Hoses recalled for potential sterility breach
FDA (Devices) · 2026-07-08
- ModerateSterile Tourniquet Hoses Recalled Due to Potential Sterility Breach
FDA (Devices) · 2026-07-08